PhD dissertations

​List of dissertations from CCIT

​2017

Shamaila Munir Ahmad, cand.scient.: T-cell responses against PD-L1 protein in cancer patients.

Per Kongsted, MD: Taxane-based chemotherapy and dendritic cell therapy in metastatic castration-resistant prostate cancer.


2015

Jon Bjørn, MD: Ipilimumab in the treatment of metastatic malignant melanoma. Immunological correlates of treatment and combination therapy.


2014

Thomas Mørch Frøsig, cand.scient.pharm.: Elucidating the immunological effects of 5-Azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.

Caroline Hasselbalch Riley, MD.: Immunological phenotype in patients with JAK2 V617F-positive chronic myeloproliferative neoplasms. Impact of immune therapy with IFN-alpha.

Mads Duus Hjortsø, cand.scient.: T-cell Recognition of Immune Modulatory Molecules in Cancer

Stine Kiær Larsen, cand. scient.Cellular Immune Responses Towards Regulatory Cells


2013

Marco Donia, MD: Methods to improve Adoptive T cell therapy with tumor infiltrating lymphocytes

Rikke Sick Andersen, cand. scient.Dissection of human melanoma specific T-cell immunity by use of combinatorial encoding MHC multimers

Trine Zeeberg Iversen, MD: Immune Modulations during Chemo-Immunotherapy & Novel Vaccine Strategies - In Metastatic Melanoma and Non Small-Cell Lung Cancer


2012

Tania Køllgaard, cand. scient.Immune regulatory cells and polymorphisms in cancer

Eva Ellebæk, MD: Dendritic cell vaccination and adoptive cell therapy in patients with metastatic malignant melanoma

Anne Ortved Gang, MD: Immune modulatory effects of azacytidine and possible implications for immunotherapy


2011

Lotte Engell-Nørregård, MD: Dendritic cell vaccination of patients with metastatic malignant melanoma​

Niels Junker, MD: Ex vivo expansion and characterization of tumor infiltrating lymphocyte derived T effector memory cells from malignant melanoma and oral squamous cell carcinoma











​​

Redaktør